The Relationship Between HER-2 Expression Levels and F-18-FDG PET/CT Parameters in Gastric Cancer
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.30, sa.3, ss.150-157, 2021 (ESCI)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 30 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.4274/mirt.galenos.2021.78055
- Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.150-157
- Anahtar Kelimeler: Gastric cancer, PET/CT, HER-2, F-18-FDG, AMERICAN-PATHOLOGISTS, GUIDELINE, SOCIETY
- Sivas Cumhuriyet Üniversitesi Adresli: Evet
Özet
Objectives: Human epidermal growth factor receptor-2 (HER-2) is a protooncogene encoded by ERBB2 on chromosome 17. (18)Fluoride-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) examination is frequently used to detect distant metastasis in gastric cancer imaging. This study aimed to investigate the relationship between the data obtained in the F-18-FDG PET/CT examination and HER-2 expression status in patients with gastric cancer.